Wireframe Ventures backs mission-driven founders at the pre-seed and seed stages who utilize advanced technology, biology, and software to dramatically improve human health and environmental sustainability.
About Wireframe Ventures
Wireframe Ventures, at wireframevc.com with LinkedIn and Crunchbase profiles, is a US-based early-stage venture firm publicly positioned around climate, sustainability, and selective adjacent technology investments. While the input fields are unfilled on stage and sector, Wireframe is best understood as a thesis-driven investor with a sustainability orientation rather than a healthcare specialist, and healthcare AI founders should engage only if their company sits at a clear intersection of healthcare and climate or sustainability. Examples of credible angles include sustainable healthcare supply chain, climate-resilient health systems, energy-efficient diagnostics infrastructure, and AI-driven public health applications focused on environmental health and pollution-related disease. Pure clinical software, hospital workflow tools, and biotech without a sustainability narrative are not the right fit and should look at healthcare-focused investors instead. Check sizes for thesis-driven seed and Series A firms in the climate space typically span USD 1M to USD 5M, with selective follow-on. Geographic preference is US-anchored with selective international deals. Best entry path is a warm introduction through the climate venture ecosystem, particularly partners at climate-focused funds or sustainability-oriented portfolio CEOs, supplemented by a LinkedIn message to a Wireframe partner that leads with the explicit climate-health intersection rather than a generic healthcare pitch. Founders should bring credible environmental impact metrics, clear sustainability differentiation, and a coherent climate thesis to the first meeting. Healthcare AI founders without a sustainability angle should redirect outreach to sector-aligned firms; pretending a thesis fit exists where it does not wastes everyone’s time and weakens the relationship for any future intersection-relevant pitch.
Founder reviews
Other portfolio companies
Companies in Wireframe Ventures's portfolio not currently in our directory.
- Enveda Biosciences · 2020
- Mammoth Biosciences · 2019
- Passkey Therapeutics · 2024
- Arise · 2022
- Think Bioscience · 2022
Team
Pitch / review this investor
Have you raised from Wireframe Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).